Investment Overview - Shanghai Youningwei Biotechnology Co., Ltd. signed a fund share transfer agreement on August 18, 2025, to acquire a property share of 15 million RMB from Shanghai Ruian Gene Technology Co., Ltd. [1] - After the transfer, the company holds a 2.6283% stake in the Hongsheng Houde Private Investment Fund Partnership [1] Investment Progress - The Hongsheng Houde Private Investment Fund has completed the necessary business registration changes and received a registration notice from the Shanghai Municipal Market Supervision Administration [1] - The fund's basic registration information includes a total contribution amount of 570.71 million RMB and was established on March 15, 2023 [1] Other Information - The company will continue to monitor the partnership's progress and fulfill its information disclosure obligations in accordance with relevant laws and regulations [1]

Core Viewpoint - Shanghai Jianhui Information Technology Co., Ltd. has announced the transfer of 15 million shares of the Shanghai Hongsheng Houde Private Equity Fund to Huang Zhihong for a transfer price of RMB 0, aiming to optimize its investment structure and focus on its core business [2][3][15]. Group 1: Transaction Overview - The company participated in the establishment of the Hongsheng Houde private equity fund in 2023, with a total fund size of RMB 570.71 million and a duration of 7 years, targeting investments in the healthcare industry [3]. - The company is a general partner in the fund, with a subscribed capital of RMB 30 million, of which RMB 15 million has been paid [3]. - The transfer agreement allows the company to transfer its unpaid capital contribution of RMB 15 million to Huang Zhihong, with the transfer price set at RMB 0 [3][8]. Group 2: Fund and Transfer Details - The Hongsheng Houde fund is a limited partnership established on March 15, 2023, with a total capital of RMB 570.71 million [6]. - The fund's main activities include private equity investment, investment management, and asset management, subject to registration with the Asset Management Association of China [7]. - The transfer does not involve any debt transfer, and the ownership of the fund shares is clear, with no encumbrances or legal disputes affecting the transfer [7][9]. Group 3: Impact on the Company - The transfer of the fund shares is part of the company's strategy to streamline external investments and focus on its main business, aligning with its overall strategic planning [15]. - The transaction is not expected to have a significant impact on the company's financial status or operational activities, nor does it harm the interests of shareholders, especially minority investors [15].